Search by Drug Name or NDC
NDC 68001-0530-69 OLOPATADINE HYDROCHLORIDE 2 mg/mL Details
OLOPATADINE HYDROCHLORIDE 2 mg/mL
OLOPATADINE HYDROCHLORIDE is a OPHTHALMIC SOLUTION in the HUMAN OTC DRUG category. It is labeled and distributed by BluePoint Laboratories. The primary component is OLOPATADINE HYDROCHLORIDE.
MedlinePlus Drug Summary
Prescription ophthalmic olopatadine (Pazeo) and nonprescription ophthalmic olopatadine (Pataday) are used to relieve itchy eyes caused by allergic reactions to pollen, ragweed, grass, animal hair, or pet dander. Olopatadine is in a class of medications called mast cell stabilizers. It works by preventing the release of substances that cause eye itching.
Related Packages: 68001-0530-69Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Olopatadine Ophthalmic
Product Information
NDC | 68001-0530 |
---|---|
Product ID | 68001-530_dbd299b7-11c8-bf59-e053-2a95a90a2cd4 |
Associated GPIs | 86802065102030 |
GCN Sequence Number | 062065 |
GCN Sequence Number Description | olopatadine HCl DROPS 0.2 % OPHTHALMIC |
HIC3 | Q6R |
HIC3 Description | EYE ANTIHISTAMINES |
GCN | 97848 |
HICL Sequence Number | 012815 |
HICL Sequence Number Description | OLOPATADINE HCL |
Brand/Generic | Generic |
Proprietary Name | OLOPATADINE HYDROCHLORIDE |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | OLOPATADINE HYDROCHLORIDE |
Product Type | HUMAN OTC DRUG |
Dosage Form | SOLUTION |
Route | OPHTHALMIC |
Active Ingredient Strength | 2 |
Active Ingredient Units | mg/mL |
Substance Name | OLOPATADINE HYDROCHLORIDE |
Labeler Name | BluePoint Laboratories |
Pharmaceutical Class | Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA209995 |
Listing Certified Through | 2024-12-31 |
Package
Package Images


NDC 68001-0530-69 (68001053069)
NDC Package Code | 68001-530-69 |
---|---|
Billing NDC | 68001053069 |
Package | 1 BOTTLE, PLASTIC in 1 CARTON (68001-530-69) / 2.5 mL in 1 BOTTLE, PLASTIC |
Marketing Start Date | 2022-04-08 |
NDC Exclude Flag | N |
Pricing Information | |
Price Per Unit | 3.04937 |
Pricing Unit | ML |
Effective Date | 2024-02-21 |
NDC Description | OLOPATADINE HCL 0.2% EYE DROP |
Pharmacy Type Indicator | C/I |
OTC | Y |
Explanation Code | 1, 5 |
Classification for Rate Setting | G |
As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis
Standard Product Labeling (SPL)/Prescribing Information SPL dbd28ee2-bbb5-a4b1-e053-2a95a90afff4 Details
Drug Facts
Do not use
When using this product
Stop use and ask a doctor if you experience:
Keep out of reach of children.
Directions
Inactive ingredients
Questions?
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL-0.2% (2.5 mL Container)
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL-0.2% (2.5 mL Container Carton)
INGREDIENTS AND APPEARANCE
OLOPATADINE HYDROCHLORIDE
olopatadine hydrochloride solution |
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
Labeler - BluePoint Laboratories (985523874) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
---|---|---|---|
Eugia Pharma Specialities Limited | 650498244 | analysis(68001-530) , manufacture(68001-530) |
Revised: 4/2022
Document Id: dbd299b7-11c8-bf59-e053-2a95a90a2cd4
Set id: dbd28ee2-bbb5-a4b1-e053-2a95a90afff4
Version: 1
Effective Time: 20220408